Abbott Neuromodulation's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS and other ...

but two others from Biotronik and Abbott Medical have not passed muster. The algorithms are designed to detect the early signs of worsening heart failure in people with CIEDs – pacemakers ...

Background: To determine the sensitivity and specificity, rate of compliance, and predictors of failure of telephone transmission of pacemaker function in a pediatric population. Methods ...

Abbott Laboratories (NYSE:ABT) has caught investor attention with the FDA’s approval of an Investigational Device Exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System, a significant ...